A European Proactive Adaptive Clinical Trials Network within EU-Response

HealthHORIZON-RIAID: 101156304
EC Contribution
โ‚ฌ170,422
Consortium Size
27 orgs
Start Year
2025
โ–ถSummary

Recent pandemics showed Europe how serious health threats can be to society. Proactive approaches are needed to ensure that medical countermeasures are available during pandemics. PROACT EU-Responseโ€™s overarching objective is to prepare Europe for future pandemics by strengthening upon existing networks of experts and civil society focused on clinical therapeutic platform trials within hospital inpatient settings across Europe. In case of an outbreak, this network will provide capacity to pivot rapidly to implement large, multi-country platform trials studying therapeutics and diagnostic-tool performance. Underpinned by strong community involvement and further strengthened by the inclusion of social and implementation scientists, PROACT EU-Response centres on six objectives: expand a solid network of clinical centres across Europe that will implement a clinical trial assessing a syndromic approach for respiratory viral infections; strengthen a laboratory network to identify pathogens and biomarkers of disease monitoring for routine surveillance; support a network of methodologists and trialists who will ensure the trialsโ€™ logistical and methodological aspects; initiate a network of professionals to work on preparedness tools to ensure a smooth pivot from inter-pandemic to the pandemic period in case of an outbreak; build a network of social science researchers who will provide nuanced understanding of the social contexts; and establish a community group to work on activities that will empower patients and citizens in Europe regarding their own health and educate them about science and health issues. By bringing together scientists, social science researchers, and civil society members, PROACT EU-Response will benefit the entire European population and beyond through decreased mortality and morbidity associated with emerging diseases, lower societal economic costs of morbidity, strengthened research and innovation expertise, human capacities, and know-how for combatting communicable diseases.

Consortium (27)

๐Ÿ‡ซ๐Ÿ‡ท INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEFR
coordinator
๐Ÿ‡ซ๐Ÿ‡ท ASSISTANCE PUBLIQUE HOPITAUX DE PARISFR
partner
๐Ÿ‡ซ๐Ÿ‡ท BIOMERIEUX SAFR
partner
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
partner
๐Ÿ‡ซ๐Ÿ‡ท Collectif No FakemedFR
partner
๐Ÿ‡ซ๐Ÿ‡ท ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORKFR
partner
๐Ÿ‡ง๐Ÿ‡ช FORUM DES PATIENTS EUROPEENSBE
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZES
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBREES
partner
๐Ÿ‡ซ๐Ÿ‡ท HOSPICES CIVILS DE LYONFR
partner
๐Ÿ‡ซ๐Ÿ‡ท INSERM TRANSFERT SAFR
partner
๐Ÿ‡ซ๐Ÿ‡ท LES MARKABIENSFR
partner
๐Ÿ‡ฆ๐Ÿ‡น MEDIZINISCHE UNIVERSITAET WIENAT
partner
๐Ÿ‡ซ๐Ÿ‡ท NILEFR
partner
๐Ÿ‡ณ๐Ÿ‡ด OSLO UNIVERSITETSSYKEHUS HFNO
partner
๐Ÿ‡ช๐Ÿ‡ธ SERVICIO MADRILENO DE SALUDES
partner
๐Ÿ‡ซ๐Ÿ‡ท SORBONNE UNIVERSITEFR
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTENNL
partner
๐Ÿ‡ฎ๐Ÿ‡น UNIVERSITA DEGLI STUDI DI VERONAIT
partner
๐Ÿ‡จ๐Ÿ‡ญ UNIVERSITAT BASELCH
partner
๐Ÿ‡ง๐Ÿ‡ช UNIVERSITE LIBRE DE BRUXELLESBE
partner
๐Ÿ‡ง๐Ÿ‡ช UNIVERSITEIT ANTWERPENBE
partner
๐Ÿ‡ฎ๐Ÿ‡ช UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINIE
partner
๐Ÿ‡ฌ๐Ÿ‡ง UNIVERSITY COLLEGE LONDONGB
partner
๐Ÿ‡ฌ๐Ÿ‡ง UNIVERSITY OF BRISTOLGB
partner
๐Ÿ‡ฎ๐Ÿ‡ช UNIVERSITY OF GALWAYIE
partner
๐Ÿ‡ฌ๐Ÿ‡ง UNIVERSITY OF LANCASTERGB
partner